Twin Study Reveals Link Between Accelerated Biological Aging and Cognitive Decline
A new study using epigenetic clocks in identical twins reveals that faster biological aging is linked to increased memory decline, especially among those from lower socioeconomic backgrounds. These findings highlight the complex interplay between genetics, environment, and brain health.
Recent research conducted by psychologists at the University of Virginia has shed light on the connection between biological aging and memory deterioration. Utilizing advanced "epigenetic clocks"—scientific tools that estimate an individual's biological age—researchers have demonstrated that these measures can effectively predict cognitive decline in middle-aged adults. The study specifically focused on identical twins to control for genetic factors, offering a clearer view of how environmental and biological influences intertwine.
The findings, published in the journal Aging by doctoral student Sophie Bell and her advisor, Professor Eric Turkheimer, revealed that within pairs of genetically identical twins, the twin exhibiting faster biological aging also showed more significant memory and cognitive deficits by midlife. This suggests that epigenetic changes—modifications in gene expression that do not alter the underlying DNA sequence—play a critical role in brain aging.
A key aspect of the study involved examining socioeconomic status. The data indicated that twins raised in environments with lower socioeconomic conditions experienced a stronger correlation between accelerated epigenetic aging and cognitive decline. This highlights the influential role of socioeconomic factors on health and aging.
Bell explained that epigenetic clocks such as GrimAge and PhenoAge are reliable markers of biological aging and can serve as predictors for cognitive deterioration. Her work also emphasizes how early-life socioeconomic disadvantages may predispose individuals to faster aging and brain decline later in life.
The research leverages decades of data from the Louisville Twin Study, which has tracked twins from childhood through midlife since 1957. The study underscores the importance of twin research as a method for isolating genetic versus environmental influences on health.
Furthermore, Bell’s ongoing clinical work with dementia patients at UVA’s Memory and Aging Care Clinic complements her research. She plans to investigate blood-based biomarkers for Alzheimer’s disease among middle-aged twins to further understand their relationship with epigenetic aging and cognitive decline.
These insights contribute to a broader understanding of how biological and environmental factors impact aging, emphasizing the need for early intervention strategies, especially for vulnerable populations affected by socioeconomic disadvantages.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Impact of Diabetes-Induced Nerve Damage on Bone Regeneration
Recent research reveals that nerve damage caused by diabetes directly impairs bone regeneration, increasing fracture risk. Understanding this nerve-bone connection offers promising avenues for innovative treatments to restore bone health in diabetic patients.
Innovative Triple-Checkpoint Therapy Shows Promise for Resistant Melanoma
New triple-checkpoint immunotherapy demonstrates promising results in treating resistant melanoma, restoring immune response and reducing tumors without added toxicity. Source: sciencex.com
Study Finds Higher Prevalence of Rare Neuroinflammatory Disease in Old Order Amish Community
Research reveals that a rare neuroinflammatory disease linked to CFI deficiency is over 4,500 times more common in the Old Order Amish community, emphasizing the importance of targeted genetic screening and personalized treatment approaches.
Innovative Mouse Models for Ultra-Rare Neurological Disorder Could Accelerate Gene Therapy Development
Researchers at Jackson Laboratory have developed new mouse models to study rare neurological disorder AHC, paving the way for potential gene editing therapies and improved understanding of disease mechanisms.